Tag: Cancer: Breast
Stressors Affect Systemic Inflammation, Tumor Aggressiveness in Breast Cancer
Perceived stress, discrimination, neighborhood deprivation linked to systemic inflammation, aggressive tumor characteristics
2.3 Million New Female Breast Cancer Cases Seen Globally in 2022
New cases and deaths set to increase by 38 and 68 percent by 2050, disproportionately affecting low-HDI countries
AI Contributes to Early Detection of Clinically Relevant Breast Cancer
Increase seen in detection of invasive cancers and in situ cancers, with reduction in screen-reading workload
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
Adding nivolumab to neoadjuvant chemotherapy significantly increases pathological complete response rates
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
Approval is targeted for patients with HER2-low or HER2-ultralow metastatic breast cancer with disease progression after endocrine therapy
FDA Approves Datroway for HR-Positive, HER2-Negative Breast Cancer
Approval is for those who have had prior therapy for unresectable or metastatic disease
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
T-DM1 sustained the improvement in invasive disease-free survival over trastuzumab in HER2-positive early breast cancer
AI-Supported Double Mammogram Reading Improves Detection Rate
Superior breast cancer detection rate seen compared with standard double-reading, without negatively affecting recall rate
Weight Gain After Breast Cancer Development Tied to Heart Failure Risk
Compared with weight maintainers, increased risk seen for 5 to 10 percent and >10 percent weight gain
Decrease Seen in In Situ Breast Cancer Since 2009
Decrease consistent with decreasing use of screening mammography since 2009 guideline change
